First Time Loading...

Aerie Pharmaceuticals Inc
NASDAQ:AERI

Watchlist Manager
Aerie Pharmaceuticals Inc Logo
Aerie Pharmaceuticals Inc
NASDAQ:AERI
Watchlist
Price: 15.25 USD 0.07% Market Closed
Updated: May 4, 2024
Section:
 

Wall Street
Price Targets

AERI Price Targets Summary
Aerie Pharmaceuticals Inc

There are no price targets for AERI.
AERI Lowest Forecast
Wall Street Target
Not Available
AERI Average Forecast
Wall Street Target
Not Available
AERI Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Aerie Pharmaceuticals Inc Competitors:
Price Targets
002900
Harbin Medisan Pharmaceutical Co Ltd
63% Upside
CTLT
Catalent Inc
2% Upside
P
PPLPHARMA
Piramal Pharma Ltd
9% Upside
W
WOCKPHARMA
Wockhardt Ltd
19% Downside
002900
Harbin Medisan Pharmaceutical Co Ltd
63% Upside
CTLT
Catalent Inc
2% Upside
P
PPLPHARMA
Piramal Pharma Ltd
9% Upside
W
WOCKPHARMA
Wockhardt Ltd
19% Downside
DRREDDY
Dr Reddy's Laboratories Ltd
5% Downside
JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
6% Downside
002626
Xiamen Kingdomway Group Co
51% Upside
GRANULES
Granules India Ltd
7% Upside

Revenue
Forecast

Revenue Estimate
Aerie Pharmaceuticals Inc

The compound annual growth rate of Aerie Pharmaceuticals Inc's revenue for the next 2 years is -5%.

N/A
Past Growth
-5%
Estimated Growth
Estimates Accuracy
7%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Aerie Pharmaceuticals Inc

Operating Income forecast
is not available for
Aerie Pharmaceuticals Inc

Net Income
Forecast

Net Income Estimate
Aerie Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
What are analyst estimates?

See Also

Summary
AERI intrinsic value, competitors valuation, and company profile.
DCF Valuation
AERI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AERI stock valuation using valuation multiples.
Wall Street Estimates
AERI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AERI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AERI's stock price target?
Not Available

AERI doesn't have any price targets made by Wall Street professionals.

What is Aerie Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
-5%

The compound annual growth rate of Aerie Pharmaceuticals Inc's revenue for the next 2 years is -5%.

ALPHA SPREAD
Join more than 134,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.